Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2010 September;52(3) > Panminerva Medica 2010 September;52(3):231-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

REVIEWS  IMAGING AND FOCAL THERAPY IN PROSTATE AND KIDNEY CANCER PART I: FOCUS ON PROSTATE


Panminerva Medica 2010 September;52(3):231-8

language: English

Salvage radical prostatectomy

Heidenreich A., Thüer D., Pfister D.

Department of Urology, RWTH University Aachen, Aachen, Germany


PDF  


Radical salvage prostatectomy represents a secondary local treatment with curative intent in patients with organ confined PCA recurrences following radiation therapy. Preoperative risk factors predicting organ confined disease are initial LDR brachytherapy, preoperative Gleason biopsy score ≤6, ≤50% biopsy cores involved with cancer, and a PSA doubling time > 12 months. Metastatic disease should be ruled out preoperatively by skeletal scintigraphy, abdominal computed tomography or magnetic resonance imaging, and/or choline – PET/CT. Functionality of the lower urinary tract is evaluated by urethrocystosocopy and urodynamics. Most appropriate candidates for radical salvage prostatectomy are patients with organ confined disease or those with symptomatic local recurrences. In experienced hands, morbidity is low with a continence rate of 83-96% depending on the type of previous radiation therapy. Long-term oncological control can be achieved in more than 80% of the patients.

top of page

Publication History

Cite this article as

Corresponding author e-mail

aheidenreich@ukaachen.de